Atlas Trials

Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses

Clinical trial NCT02952898 · COMPLETED

Trial details

NCT number
NCT02952898
Sponsor
Balmoral Medical company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Actinic Keratosis
Start date
2016-10-27
Primary completion
2017-07-11
Enrollment
665

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.